Article
Decitabine Promotes Modulation in Phenotype and Function of Monocytes and Macrophages That Drive Immune Response Regulation.
Cells - 12 Apr 2021
Zambuzi Fabiana Albani, Cardoso-Silva Priscilla Mariane, Castro Ricardo Cardoso, Fontanari Caroline, Emery Flavio da Silva, Frantz Fabiani Gai
Abstract excerpt
Decitabine is an approved hypomethylating agent used for treating hematological malignancies. Although decitabine targets altered cells, epidrugs can trigger immunomodulatory effects, reinforcing the hypothesis of immunoregulation in treated patients. We therefore aimed to evaluate the impact of decitabine treatment on the phenotype and functions of monocytes and macrophages, which are pivotal cells of the innate...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
